You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CtDNA

Showing 1 - 25 of 1,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,

Recruiting
  • Metastatic Colorectal Cancer
  • +2 more
  • ctDNA and adjuvant therapy
  • ctDNA
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 22, 2022

ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

Recruiting
  • Ovarian Cancer Stage IV
  • Ovarian Cancer Stage III
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital
    Aug 30, 2023

    ctDNA Testing Plus AI-based Pathology in Resectable LSCC

    Recruiting
    • Lung Squamous Cell Carcinoma
    • WES and ctDNA detection
    • Changsha, Hunan, China
      Department of Thoracic Surgery, Second Xiangya Hospital of Centr
    Mar 18, 2023

    Ovarian Cancer Trial in Roma (Blood samples)

    Not yet recruiting
    • Ovarian Cancer
    • Blood samples
    • Roma, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Oct 3, 2023

    Chemoresistance Mechanisms in Pancreatic Cancer

    Not yet recruiting
    • Patients With Non-metastatic Pancreatic Cancer
    • Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
    • ctDNA detection
    • Shanghai, Shanghai, China
      Zhongshan Hospital
    Apr 27, 2023

    ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • SIGNATERA™ ctDNA testing
    • Fairfax, Virginia
      Inova Schar Cancer Institute
    Oct 26, 2022

    Appendiceal Adenocarcinoma, Colorectal Trial in Houston (Circulating tumoral DNA directed neoadjuvant therapy arm)

    Not yet recruiting
    • Appendiceal Adenocarcinoma
    • Colorectal
    • Circulating tumoral DNA directed neoadjuvant therapy arm
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 7, 2023

    Older Women With ER+ Breast Cancer Who Omit Surgery

    Recruiting
    • Breast Cancer
      • Pittsburgh, Pennsylvania
        UPMC Magee Womens Hospital - Surgical Oncology
      Jun 13, 2023

      ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • NGS and ctDNA-MRD detection
      • Changsha, Hunan, China
        Department of Thoracic Surgery, Second Xiangya Hospital of Centr
      Apr 18, 2023

      Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

      Not yet recruiting
      • Minimal Residual Disease
      • Esophageal Squamous Cell Carcinoma
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Jun 10, 2023

        Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

        Recruiting
        • Esophageal Squamous Cell Carcinoma
          • Shijiazhuang, Hebei, China
            Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
          Oct 25, 2023

          Postoperative Recurrence in Biliary Tract Cancers:A Multicenter

          Recruiting
          • Biliary Tract Cancer
          • No intervention
          • Nanjing, Jiangsu, China
            The First Affiliated Hospital with NanJing Medical University
          Feb 15, 2023

          ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

          Recruiting
          • Breast Cancer Female
          • +4 more
            • Ho Chi Minh City, Vietnam
            • +1 more
            Oct 16, 2023

            Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

            Active, not recruiting
            • Melanoma
              • Murray, Utah
              • +1 more
              Feb 17, 2023

              Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

              Recruiting
              • Carcinoma
              • +4 more
                • Nanjing, Jiangsu, China
                  Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
                Jun 30, 2023

                Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

                Recruiting
                • Pediatric Soft Tissue Sarcoma
                • detection and monitoring of cirulating tumor DNA
                • Guangzhou, Guangdong, China
                  Sun Yat-sen University Cancer Center
                Mar 20, 2023

                ctDNA-MRD in Predicting Efficacy of Esophageal Squamous Cell

                Not yet recruiting
                • Squamous Cell Carcinoma of Esophagus
                  • (no location specified)
                  Feb 25, 2023

                  Pancreatic Cancer, Advanced Cancer, Metastatic Cancer Trial in Beijing (Later-line therapy)

                  Recruiting
                  • Pancreatic Cancer
                  • +2 more
                  • Later-line therapy
                  • Beijing, Beijing, China
                    Peking Union Medical College Hospital
                  Apr 10, 2023

                  Non Small Cell Lung Cancer Trial in Seoul (Lazertinib+Pemetrexed+Carboplatin, Lazertinib)

                  Not yet recruiting
                  • Non Small Cell Lung Cancer
                  • Seoul, Korea, Republic of
                    Yonsei University Health System, Severance Hospital
                  Aug 31, 2023

                  ctDNA Methylation for Epithelial Ovarian Cancer

                  Recruiting
                  • Epithelial Ovarian Cancer
                  • +7 more
                  • CDO1 and HOXA9 methylation assay
                  • Beijing, Beijing, China
                    Lei Li
                  Mar 24, 2023

                  Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

                  Recruiting
                  • Gastrointestinal Stromal Tumors
                  • Miami, Florida
                    University of Miami
                  Jan 3, 2023

                  Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)

                  Not yet recruiting
                  • Breast Cancer
                  • (no location specified)
                  Feb 1, 2023

                  Pancreatic Cancer, Resectable Carcinoma Trial in Beijing (Later-line therapy)

                  Recruiting
                  • Pancreatic Cancer
                  • Resectable Carcinoma
                  • Later-line therapy
                  • Beijing, China
                    Department of Medical Oncology, Peking Union Medical College Hos
                  Apr 10, 2023

                  ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality

                  Recruiting
                  • Bladder Cancer
                  • Muscle-Invasive Bladder Carcinoma
                    • Chapel Hill, North Carolina
                      North Carolina Cancer Hospital (UNC)
                    Jan 11, 2023

                    Patient Decision Making in Early Stage Breast Cancer:Conjoint

                    Recruiting
                    • Triple Negative Breast Cancer
                      • Indianapolis, Indiana
                        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
                      Feb 14, 2023